ArticleEuropean journal of nuclear medicine and molecular imaging2025

Editorial Commentary: Should "heterogeneous response" be considered as new category for assessing treatment response in patients with breast cancer?

Sofia C Vaz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.